IRVINE, Calif.--(BUSINESS WIRE)--PrimeCell™ Therapeutics LLC (http://www.primecelltherapeutics.com) today announced that the company has been invited to participate in a series of events and discussions on stem cell research this week in Washington, D.C., and to provide input regarding new legislation being proposed in the House of Representatives that would require stem cell research funding to be prioritized based on its near term probability of benefiting patients in the clinic.
